Showing results (2021-2030 of 2,164) with videos related to
Sort By:
Pageof 217
International Journal of Obesity (2005)|August 12, 2014
Ectopic cardiovascular fat in middle-aged men: effects of race/ethnicity, overall and central adiposity. The ERA JUMP studyS R El Khoudary, C Shin, K Masaki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2023
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing CancersTimothy P DiPeri, Kurt W Evans, Maria Gabriela Raso, et al.The Journal of Nutrition|August 6, 2010
Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cellsHuijun Chen, Zouhair K Attieh, Basharut A Syed, et al.American Journal of Hypertension|July 4, 2013
Association of total marine fatty acids, eicosapentaenoic and docosahexaenoic acids, with aortic stiffness in Koreans, whites, and Japanese AmericansAkira Sekikawa, Chol Shin, Kamal H Masaki, et al.BBA Clinical|April 1, 2015
Lipoprotein particles and size, total and high molecular weight adiponectin, and leptin in relation to incident coronary heart disease among severely obese postmenopausal women: The Women's Health Initiative Observational StudyRachel H Mackey, Kathleen M McTigue, Yuefang F Chang, et al.Cancer Research|January 4, 2008
Homologous recombination is the principal pathway for the repair of DNA damage induced by tirapazamine in mammalian cellsJames W Evans, Sophia B Chernikova, Lisa A Kachnic, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cellsW Nicholas Haining, Benjamin L Ebert, Aravind Subrmanian, et al.Scientific Reports|November 19, 2023
Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancerTurcin Saridogan, Argun Akcakanat, Ming Zhao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2017
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type TumorsKurt W Evans, Erkan Yuca, Argun Akcakanat, et al.Science Advances|July 11, 2017
WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell deathMarcus M Fischer, Belinda Cancilla, V Pete Yeung, et al.Pageof 217